A detailed history of Creative Planning transactions in Spring Works Therapeutics, Inc. stock. As of the latest transaction made, Creative Planning holds 5,587 shares of SWTX stock, worth $284,322. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,587
Previous 7,921 29.47%
Holding current value
$284,322
Previous $253,000 20.55%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$28.61 - $42.55 $66,775 - $99,311
-2,334 Reduced 29.47%
5,587 $201,000
Q3 2024

Oct 11, 2024

BUY
$32.04 - $42.76 $253,788 - $338,701
7,921 New
7,921 $253,000
Q1 2024

May 10, 2024

BUY
$36.5 - $52.5 $191,479 - $275,415
5,246 New
5,246 $258,000

Others Institutions Holding SWTX

About SpringWorks Therapeutics, Inc.


  • Ticker SWTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,401,100
  • Market Cap $3.18B
  • Description
  • SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...
More about SWTX
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.